Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Hashizume

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Histology and Cytology|December 28, 2002
Three-dimensional cytoarchitecture of angiogenic blood vessels in a gelatin sheet implanted in the rat skeletal muscular layersHiroya Hashizume, Tatsuo Ushiki
Current Opinion in Genetics & Development|January 22, 2005
Cellular abnormalities of blood vessels as targets in cancerPeter Baluk, Hiroya Hashizume, Donald M McDonald
Clinical Neuropharmacology|August 10, 2022
Persistent Hiccups Induced by Supratentorial Infarcts and Successful Treatment With a Combination of Perampanel and Baclofen: A Case ReportKohei Morita, Yoshitsugu Nuki, Hiroya Hashizume, et al.
The American Journal of Pathology|October 10, 2009
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vesselsBeverly L Falcón, Hiroya Hashizume, Petros Koumoutsakos, et al.
Calcified Tissue International|March 13, 2026
Prognostic Nutritional Index is a Superior Predictor to Geriatric Nutritional Risk Index for 1-Year Mortality in Older Adult Patients with Proximal Femoral FracturesShu Yamazaki, Tomohiro Shimizu, Hotaka Ishizu, et al.
Cancer Research|May 27, 2011
VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancerWeon-Kyoo You, Barbara Sennino, Casey W Williamson, et al.
Cancer Research|March 4, 2010
Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growthHiroya Hashizume, Beverly L Falcón, Takashi Kuroda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2007
Endogenous endostatin inhibits choroidal neovascularizationAlexander G Marneros, Haicheng She, Hadi Zambarakji, et al.
The Journal of Experimental Medicine|September 12, 2007
Functionally specialized junctions between endothelial cells of lymphatic vesselsPeter Baluk, Jonas Fuxe, Hiroya Hashizume, et al.
The American Journal of Pathology|June 25, 2004
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghostsTetsuichiro Inai, Michael Mancuso, Hiroya Hashizume, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Histology and Cytology|December 28, 2002
Three-dimensional cytoarchitecture of angiogenic blood vessels in a gelatin sheet implanted in the rat skeletal muscular layersHiroya Hashizume, Tatsuo Ushiki
Current Opinion in Genetics & Development|January 22, 2005
Cellular abnormalities of blood vessels as targets in cancerPeter Baluk, Hiroya Hashizume, Donald M McDonald
Clinical Neuropharmacology|August 10, 2022
Persistent Hiccups Induced by Supratentorial Infarcts and Successful Treatment With a Combination of Perampanel and Baclofen: A Case ReportKohei Morita, Yoshitsugu Nuki, Hiroya Hashizume, et al.
The American Journal of Pathology|October 10, 2009
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vesselsBeverly L Falcón, Hiroya Hashizume, Petros Koumoutsakos, et al.
Calcified Tissue International|March 13, 2026
Prognostic Nutritional Index is a Superior Predictor to Geriatric Nutritional Risk Index for 1-Year Mortality in Older Adult Patients with Proximal Femoral FracturesShu Yamazaki, Tomohiro Shimizu, Hotaka Ishizu, et al.
Cancer Research|May 27, 2011
VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancerWeon-Kyoo You, Barbara Sennino, Casey W Williamson, et al.
Cancer Research|March 4, 2010
Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growthHiroya Hashizume, Beverly L Falcón, Takashi Kuroda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2007
Endogenous endostatin inhibits choroidal neovascularizationAlexander G Marneros, Haicheng She, Hadi Zambarakji, et al.
The Journal of Experimental Medicine|September 12, 2007
Functionally specialized junctions between endothelial cells of lymphatic vesselsPeter Baluk, Jonas Fuxe, Hiroya Hashizume, et al.
The American Journal of Pathology|June 25, 2004
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghostsTetsuichiro Inai, Michael Mancuso, Hiroya Hashizume, et al.
Pageof 2